PITANDS/PANDAS

[Ronnas]

I have posted some of these in the past but I thought I would do so again. R.

 

 

Mycoplasma pneumoniae infection and Tourette's syndrome.

 

Muller N, Riedel M, Blendinger C, Oberle K, Jacobs E, Abele-Horn M.

Hospital for Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munchen, Nussbaumstrasse 7, D-80336 Munchen, Germany. nmueller@psy.med.uni-muenchen.de

 

An association between infection and Tourette's syndrome (TS) has been described repeatedly. A role for streptococcal infection (PANDAS) has been established for several years, but the involvement of other infectious agents such as Borrelia Burgdorferi or Mycoplasma pneumoniae has only been described in single case reports. We examined antibody titers against M. pneumoniae and various types of antibodies by immunoblot in patients and in a sex- and age-matched comparison group. Participants comprised 29 TS patients and 29 controls. Antibody titers against M. pneumoniae were determined by microparticle agglutination (MAG) assay and confirmed by immunoblot. Elevated titers were found in significantly more TS patients than controls (17 vs. 1). Additionally, the number of IgA positive patients was significantly higher in the TS group than in the control group (9 vs. 1). A higher proportion of increased serum titers and especially of IgA antibodies suggests a role for M. pneumoniae in a subgroup of patients with TS and supports the finding of case reports implicating an acute or chronic infection with M. pneumoniae as one etiological agent for tics. An autoimmune reaction, however, has to be taken into account. In predisposed persons, infection with various agents including M. pneumoniae should be considered as at least an aggravating factor in TS.

 

PMID: 15590039 [PubMed - indexed for MEDLINE]

 

 

1: Pediatr Neurol. 2004 Aug;31(2):119-21. Links

Restless legs syndrome: association with streptococcal or mycoplasma infection.Matsuo M, Tsuchiya K, Hamasaki Y, Singer HS.

Department of Pediatrics, Faculty of Medicine, Saga University, Saga, Japan.

 

Group A beta-hemolytic streptococcal infections have been reported to cause neuropsychiatric symptoms, such as chorea, tics, and obsessive-compulsive disorder, presumably through autoimmune damage to basal ganglia. Mycoplasma pneumoniae infections have also been reported to cause damage to the basal ganglia. Restless legs syndrome is a movement disorder with focal restlessness, an irresistible desire to move, and exacerbation by long periods of sitting or lying. We present three children with transient restless legs syndrome-like symptoms possibly associated with group A beta-hemolytic streptococcal infection or Mycoplasma pneumoniae infection. One of three patients had persistently elevated enzyme-linked immunosorbent optical density values against human caudate and putamen.

 

PMID: 15301831 [PubMed - indexed for MEDLINE]

 

Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder

.Mell LK, Davis RL, Owens D.

Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA.

 

OBJECTIVE: Reports have suggested that streptococcal infection may be etiologically related to pediatric autoimmune neuropsychiatric disorders (PANDAS), but there are few good epidemiologic studies to support this theory. Using population-based data from a large West-Coast health maintenance organization, we assessed whether streptococcal infection was associated with increased risk for obsessive-compulsive disorder (OCD), Tourette's syndrome (TS), or tic disorder. METHODS: This is a case-control study of children 4 to 13 years old receiving their first diagnosis of OCD, TS, or tic disorder between January 1992 and December 1999 at Group Health Cooperative outpatient facilities. Cases were matched to controls by birth date, gender, primary physician, and propensity to seek health care. RESULTS: Patients with OCD, TS, or tic disorder were more likely than controls to have had prior streptococcal infection (OR: 2.22; 95% CI: 1.05, 4.69) in the 3 months before onset date. The risk was higher among children with multiple streptococcal infections within 12 months (OR: 3.10; 95% CI: 1.77, 8.96). Having multiple infections with group A beta-hemolytic streptococcus within a 12-month period was associated with an increased risk for TS (OR: 13.6; 95% CI: 1.93, 51.0). These associations did not change appreciably when limited to cases with a clear date of onset of symptoms or with tighter matching on health care behavior. CONCLUSION: These findings lend epidemiologic evidence that PANDAS may arise as a result of a postinfectious autoimmune phenomenon induced by childhood streptococcal infection.

 

 

: J Am Acad Child Adolesc Psychiatry. 1997 Aug;36(8):1128-33. Links

Comment in:

J Am Acad Child Adolesc Psychiatry. 1999 Mar;38(3):228-9.

J Am Acad Child Adolesc Psychiatry. 2000 Jul;39(7):810-2.

Case study: an infection-triggered, autoimmune subtype of anorexia nervosa.Sokol MS, Gray NS.

Eating Disorders Program, Menninger Clinic, Topeka, KS, USA. sokolms@menninger.edu

 

OBJECTIVE: Certain cases of anorexia nervosa (AN) may be similar to the recently described subtype of childhood-onset obsessive-compulsive disorder hypothesized to be one of the pediatric infection-triggered autoimmune neuropsychiatric disorders (PITANDs). METHOD: Three clinical cases are reported. The first patient is a 12-year-old boy whose AN worsened acutely after a group A beta-hemolytic streptococcal (GABHS) infection. His symptoms were alleviated after antibiotic treatment. Two other patients with possible PITANDs-related AN are described. RESULTS: An infection-triggered process may contribute to the pathogenesis of a subtype of AN. CONCLUSIONS: Future research is needed to explore the nature of PITANDs and their relationship with AN.

[Chemar]

thanks Ronna

[Laurensmom]

Great info, thanks so much.

 

Does anyone know if Garlic (a natural antiviral/antibiotic) is helpful with some of these issues?

[Dedee]

Ronna,

 

That is so interesting about restless leg syndrome in post strept. individuals. I have had RLS for many years, and last year my middle son started crying at bedtime with complaints that his legs would not "stop moving". It was very hard for him to describe, but I understood completely. He was almost 6 at the time, and started sleeping with me so that I could soothe him and help him get to sleep. I discussed this with my sister (who has RLS also) and my husband after it continued for over a month and started to talk to the pediatrician about it, but I truely thought she would think I was crazy. Finally after a few months my son settled down and only complains when extremely tired now. He still has difficulty getting to sleep some. For the life of me though, I can not remember if there was an associated Strep around that time or not. He has had several infections just as his older brother, who has PANDAS. I only watched for that sudden onset of OCD back then as that was all we were aware of at the time. I am so much more in tune now.

 

Anyway, I thought that was interesting. Thanks for the post.

 

Dedee

[Chemar]

bumping up for Michele, Dedee and Faith

[Ronnas]

Below I have copied a journal article that I think is one of the best from the Canadian Medical Association Journal. A single ASO is not informative, rather serial ASO titers that show that elevating or declining numbers is much more informative...

 

"Initial investigations in children with a history suggestive of streptococcal infection or a strong family history of rheumatic fever, or both, should include throat cultures and antistreptolysin O titres. [b]These titres should be repeated after an interval of approximately 3–4 weeks, because a correlation of symptom severity with changes in antibody levels is far more informative than an isolated antistreptolysin O titre."[/b]

 

http://www.cmaj.ca/cgi/content/full/165/10/1353

 

 

Is obsessive–compulsive disorder an autoimmune disease?

Paul D. Arnold and Margaret A. Richter

Dr. Arnold is Fellow, Children's Mood and Anxiety Service and Neurogenetics Section, and Dr. Richter is Staff Psychiatrist, Anxiety Disorders Clinic, the Centre for Addiction and Mental Health, University of Toronto, Toronto, Ont.

 

 

Correspondence to: Dr. Margaret A. Richter, Centre for Addiction and Mental Health, 250 College St., Toronto ON M5T 1R8; fax 416 979-6853; peggy_richter@camh.net

 

Abstract

 

OBSESSIVE–COMPULSIVE DISORDER (OCD) IS A COMMON and debilitating neuropsychiatric disorder. Although it is widely believed to have a genetic basis, no specific genetic factors have been conclusively identified as yet, leading researchers to look for environmental risk factors that may interact with an underlying genetic susceptibility in affected individuals. Recently, there has been increasing interest in a possible link between streptococcal infections and the development of OCD and tic disorders in children. It has been suggested that OCD in some susceptible individuals may be caused by an autoimmune response to streptococcal infections, that is, a similar biological mechanism to that associated with Sydenham's chorea. The term "pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections" (PANDAS) has been used to describe a subset of children with abrupt onset or exacerbations of OCD or tics, or both, following streptococcal infections. Affected children have relatively early symptom onset, characteristic comorbid symptoms and subtle neurological dysfunction. Neuroimaging studies reveal increased basal ganglia volumes, and the proposed cause involves the cross-reaction of streptococcal antibodies with basal ganglia tissue. Vulnerability to developing PANDAS probably involves genetic factors, and elevated levels of D8/17 antibodies may represent a marker of susceptibility to PANDAS. Prophylactic antibiotic treatments have thus far not been shown to be helpful in preventing symptom exacerbations. Intravenous immunoglobulin therapy may be an effective treatment in selected individuals. Further understanding of the role of streptococcal infections in childhood-onset OCD will be important in determining alternative and effective strategies for treatment, early identification and prevention of this common and debilitating psychiatric disorder.

 

 

 

--------------------------------------------------------------------------------

Obsessive–compulsive disorder (OCD) is a common and debilitating disorder, which an estimated 2%–4% of individuals will develop before the age of 18 years.1 The pathogenesis is presumed to involve basal ganglia dysfunction2,3 and underlying genetic factors.4,5 Compared with adults, children with OCD are more likely to be male1 and to have comorbid Tourette's syndrome, which is another highly familial disorder attributed to basal ganglia dysfunction6 that many investigators believe may result from the same underlying diathesis.7,8

Recently, there has been increasing interest in a possible link between streptococcal infections and OCD and tic disorders in children.9 A subtype of childhood OCD known as "pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections" (PANDAS)9,10 has been postulated. The purpose of this review is to provide clinicians with an overview of the PANDAS concept and information regarding the clinical presentation, prevalence, pathophysiology, predisposing factors and treatment of this condition.

 

Sydenham's chorea: a medical model for OCD

 

Sydenham's chorea, which is a neuropsychiatric syndrome that usually occurs in prepubertal children, may represent a "medical model" of onset of OCD in childhood. Sydenham's chorea develops following group A ß-hemolytic streptococcal infections and is one manifestation of rheumatic fever according to the Jones criteria.11 In a process known as "molecular mimicry," antistreptococcal antibodies cross-react with basal ganglia proteins, triggering an inflammatory response and producing the symptoms of Sydenham's chorea.9

 

In addition to the chorea that gives the syndrome its name, there are characteristic psychiatric symptoms, including a syndrome similar to attention-deficit hyperactivity disorder and emotional lability.12,13,14 Obsessive–compulsive symptoms, which were first described in patients with Sydenham's chorea by Osler,15 have been well documented in prospective studies of the syndrome14,16 leading to the suggestion that OCD may represent a "forme fruste," or an atypical, incomplete form, of Sydenham's chorea.17

 

PANDAS: a proposed OCD subtype

 

Longitudinal studies of children with OCD identified a subgroup with a course of illness characterized by the dramatic onset of symptoms or their exacerbation, or both,9,10 one-third of whom exhibited "choreiform" movements resembling the chorea of Sydenham's chorea.18 The exacerbations of symptoms in some of these children were correlated with a history of recent streptococcal infections.9,10 Studies of children presenting with tics19 also raised the possibility that some children with neuropsychiatric disorders have symptoms caused or exacerbated by streptococcal infections.

 

Following up on these early clinical observations, a group based at the US National Institute of Mental Health recruited children with presumed streptococcal-induced OCD based on a set of diagnostic criteria that they had developed. The term "pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections" (PANDAS) was coined to describe a putative subtype of children with OCD and tic disorders who met all 5 working criteria.9 Table 1 summarizes these criteria and other diagnostic guidelines gleaned from the current literature.10,20

 

 

 

 

View this table:

[in this window]

[in a new window]

Table 1.

 

 

 

 

 

The prevalence of PANDAS is unknown. There is one report on the prevalence of streptococcal-induced exacerbations in a group of children presenting with tics, 11% of whom had a history of exacerbations within 6 weeks of a streptococcal infection.21 Limitations of this study include its setting in a highly specialized clinic, which limits its generalizability to other populations with tic disorders, and its reliance on retrospective historical data instead of objective laboratory findings such as antistreptococcal antibodies. Two studies have evaluated antistreptococcal antibodies in subjects with Tourette's syndrome compared with controls, and in both of these studies significantly elevated titres were observed in the subjects with Tourette's syndrome.22,23 Antistreptococcal antibody levels were found to correlate with severity of symptoms in one report.22

 

The PANDAS syndrome is believed to result from antistreptococcal antibodies that have cross-reacted with basal ganglia tissue, as has been demonstrated in Sydenham's chorea. Consistent with this model, the following findings have been reported: significantly elevated antineuronal antibodies in children with PANDAS24 and related neuropsychiatric disorders,25,26,27 increased basal ganglia volumes on volumetric MRI28 in subjects with PANDAS and higher antistreptococcal antibodies that correlated with increased basal ganglia volumes in subjects with either attention-deficit hyperactivity disorder or OCD.29 Taken together, these findings are consistent with autoimmune-mediated inflammation of the basal ganglia, although further research is required to confirm this association, and many unanswered questions remain. For example, it is not clear whether this autoimmune mechanism is specific to OCD and tic disorders or has implications for other childhood neuropsychiatric disorders. This was highlighted by a recent study reporting a significant correlation of antistreptococcal antibody titres with a diagnosis of attention-deficit hyperactivity disorder, but not with OCD or tic disorders.29

 

Predisposing factors for PANDAS

 

Streptococcal infections are ubiquitous in childhood, however, neuropsychiatric disorders are not, suggesting that only certain individuals are predisposed to develop the PANDAS phenotype.9 Vulnerable individuals may have a genetic predisposition to developing neurotransmitter dysfunction or to formation of antistreptococcal antibodies that cross-react with neuronal proteins, or may have a form of immune dysregulation, or both.

 

D8/17, which is a monoclonal antibody that identifies a specific B lymphocyte cell-surface marker, is one possible susceptibility factor for PANDAS. Significantly elevated levels of this marker have been found in individuals with rheumatic fever and to a lesser extent in their family members when compared with controls. It is, thus, considered a possible trait marker, indicating genetic susceptibility to rheumatic fever (and by inference, to Sydenham's chorea).30,31 To date, elevated levels of antibodies that recognize the D8/17 marker have been demonstrated in children with PANDAS,32 and more generally in subjects with early onset OCD and tic disorders.33,34 In a sample of children with autism, D8/17 expression was shown to be significantly correlated with compulsive behaviour.35 Although the D8/17 data are suggestive, the functional significance of this marker is unknown,30,31 and further investigation is needed to clarify its etiological and clinical significance.

 

Elevated rates of tic disorders and OCD have been reported in first-degree relatives of children with PANDAS, which is comparable to previous observations in relatives of individuals with OCD and tic disorders, indicating that genetic factors may be important in conferring vulnerability to the PANDAS subtype.36 However, although a number of candidate genes have been implicated in OCD,37,38,39,40,41 there are no published reports of molecular genetics studies of individuals with PANDAS.

 

A few studies have measured cytokines or immune cells in subjects with OCD. In addition to acting as protein messengers between immune cells, cytokines are also known to influence central nervous system signalling and, therefore, may play a role in the pathophysiology of a number of psychiatric and neurological disorders.42 A relative skewing toward type 1 cytokine production in cerobrospinal fluid has been demonstrated in pediatric patients with OCD.43 Various immunological abnormalities reported in adult subjects with OCD44,45,46,47 have not been consistently replicated, and other studies have produced negative findings.48,49,50

 

In summary, although it is presumed that individuals who develop PANDAS in the presence of streptococcal infections are vulnerable as a result of a genetic predisposition or a form of immune dysregulation, or both, this has yet to be clearly demonstrated. Interesting preliminary findings in PANDAS that require further investigation include the presence of elevated levels of D8/17 antibodies, elevated rates of tic disorders and OCD in first-degree relatives, and immunological abnormalities reported in individuals with OCD.

 

Approach to the diagnosis of PANDAS

 

We recommend evaluation of all children who present with the sudden onset or exacerbation of obsessive–compulsive symptoms, using the approach summarized in Fig. 1. This diagnostic algorithm, which is based on the literature summarized earlier as well as our clinical judgement, begins with a history-taking, mental status examination and focused physical examination. Initial investigations in children with a history suggestive of streptococcal infection or a strong family history of rheumatic fever, or both, should include throat cultures and antistreptolysin O titres. These titres should be repeated after an interval of approximately 3–4 weeks, because a correlation of symptom severity with changes in antibody levels is far more informative than an isolated antistreptolysin O titre. We recommend antistreptolysin O titre, because the other antistreptococcal test reported in the PANDAS literature, namely, antideoxyribonuclease-B (antiDNAse , is expensive and not widely available in Canada. The D8/17 marker is an experimental assay that is not available for routine clinical use.

 

 

 

 

 

View larger version (44K):

[in this window]

[in a new window]

Fig. 1: Assessment and treatment of children presenting with abrupt-onset obsessive–compulsive disorder (OCD) or tic disorders. ADHD = attention-deficit hyperactivity disorder, ASO = antistreptolysin O, CBT = cognitive behavioural therapy, SRIs = serotonin reuptake inhibitors, NIMH = US National Institute of Mental Health, PANDAS = pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

 

 

 

 

 

Treatment of PANDAS

 

Current first-line treatments for OCD include pharmacological treatment with serotonin reuptake inhibitors (SRIs) and cognitive behavioural therapy. Researchers have reported response rates of between 50% and 75% for pharmacotherapy1 and from 67% to 100% for cognitive behavioural therapy.1,51 With the accumulating evidence that PANDAS represents a distinct autoimmune subtype, it is now possible to examine various therapies for the disorder targeting either the infectious trigger for the illness or the immune response itself. Recently, 2 randomized controlled trials have evaluated these approaches to the treatment of children with PANDAS.52,53 In the first study, patients received either 4 months of penicillin V administered orally followed by 4 months of placebo, or placebo followed by penicillin V. There was no difference between the active and placebo phases in the severity of obsessive–compulsive symptoms or tics. However, the penicillin regimen used was ineffective in preventing infections and, consequently, no conclusions could be drawn regarding the efficacy of penicillin prophylaxis in preventing exacerbations of tics or OCD symptoms.52

 

In the second study, children with severe PANDAS received one of 3 treatments: plasma exchange, intravenous immunoglobulin, or placebo (sham intravenous immunoglobulin). When subjects were assessed one and 12 months post treatment and compared with the placebo group, both plasma exchange and intravenous immunoglobulin were associated with striking improvements on standardized scales that measure obsessive–compulsive symptoms, anxiety and overall functioning.53 An open trial of plasma exchange in a small group of children with treatment-refractory OCD without a history of streptococcal infections failed to show any therapeutic benefit.54 These findings demonstrate that immunomodulatory treatments may represent an efficacious treatment for PANDAS specifically and are probably ineffective in treating other forms of OCD. Plasma exchange and intravenous immunoglobulin are highly invasive, require admission to hospital and have not been directly compared with more traditional therapies such as serotonergic medications and cognitive behavioural therapy. However, as a result of recent publicity surrounding PANDAS, parents and physicians in the United States have been seeking immunomodulatory treatments for children with OCD and tic disorders despite the potential risks. This has led the US National Institute of Mental Health to issue a warning to parents and clinicians that plasma exchange and intravenous immunoglobulin are not to be used outside research protocols.55

 

Our recommended approach to treatment, based on the literature summarized above as well as our clinical judgement, is summarized in Fig. 1. Standard therapies shown to be efficacious in the treatment of OCD51 and tic disorders56 should still be used as first-line treatment, accompanied by careful monitoring and early treatment of group A ß-hemolytic streptococcal infections. However, in treatment-refractory children with a clear PANDAS course, prophylactic antibiotics might be considered in consultation with a pediatrician. To our knowledge, immunomodulatory treatments are not currently available anywhere in Canada for the treatment of childhood neuropsychiatric disorders. Physicians who are seeking treatment for a child with PANDAS are encouraged to contact the US National Institute of Mental Health directly (www.nimh.nih.gov) regarding ongoing clinical trials.

 

 

Childhood-onset obsessive–compulsive disorder

Lifetime prevalence: 2%–4%

 

Pathogenesis: genetic causes, basal ganglia dysfunction

 

Children with this disorder are more likely to be male and to have comorbid Tourette's syndrome or tics

 

 

Sydenham's chorea

Poststreptococcal syndrome that usually occurs in prepubertal children

 

Pathogenesis: mechanism of "molecular mimicry" in which antistreptococcal antibodies cross-react with basal ganglia proteins

 

Psychiatric symptoms: obsessive–compulsive behaviour, emotional lability, "attention-deficit hyperactivity disorder–like" syndrome

 

 

Evidence regarding the origin and pathogenesis of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)

Elevated antineuronal antibodies

 

Increased basal ganglia volume measured using volumetric MRI

 

Elevated levels of cells expressing the D8/17 marker

 

Positive family history of obsessive–compulsive disorder and tic disorders

 

Evidence of response to immunomodulatory therapies